Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBLOCK-2: Aldosterone receptor blockade in chronic kidney disease
2009-012445-35Phase 3Terminated
- Sponsor
- Herlev Hospital
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of eplerenone in chronic kidney disease (CKD), sponsored by Herlev Hospital. Primary endpoint: Change in arterial stiffness (PWV). Started Oct 2009; status: terminated.
02
Drugs
eplerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2009-012445-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012445-35.